BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2008
View Archived Issues
Improved in vitro profile and therapeutic index with Pfizer's new bronchodilator UK-503590
Read More
Targeting the GPR4 receptor shows benefit in models of lung injury and COPD
Read More
Johnson & Johnson new LTA4H inhibitor reduces allergic airways inflammation in vivo
Read More
ST-2472 exhbits potent antipsychotic effects and good safety profile in vivo
Read More
Antitumor effects of chemotherapy enhanced by inhibition of N-cadherin
Read More
Novel mechanism for benzodiazepine receptor ligand PK-11195 identified
Read More
Medivir reports new therapeutic options for HCV infection in recent patent
Read More
Recent patents describe novel treatment alternatives for eye disorders
Read More
Recent patents disclose novel anti-HIV agents
Read More
Recent patents impart novel treatment options for cancer
Read More
DOR BioPharma withdraws E.U. MAA for orBec and plans phase III study
Read More
Allon completes dosing in phase II AL-208 cognitive impairment trial
Read More
FDA issues approvable letter for bazedoxifene in postmenopausal osteoporosis
Read More
GTx phase III toremifene trial continues after interim efficacy analysis
Read More
Novo Nordisk files for regulatory approval of liraglutide in the U.S. and Europe
Read More
ProStrakan grants exclusive license to JapanBridge for Sancuso in parts of Asia
Read More
Panobinostat active against poorly differentiated and anaplastic thyroid carcinoma cells
Read More
First patients enrolled in switch trial of oral iclaprim
Read More
Synthetic Blood International obtains exclusive license to VCU discoveries
Read More
Draxis Health acquisition approved by shareholders
Read More
First MS therapeutic from Novartis approved for launch in Europe
Read More
